Stockreport

Better Buy: Inovio Pharmaceuticals vs. GlaxoSmithKline [The Motley Fool]

GlaxoSmithKline PLC  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF In one corner, we have a small and scrappy biotech that has received a lot of attention this year as its stock skyrocketed. In the other corner, there's a big pharmaceut [Read more]